VANCOUVER, British Columbia, Aug. 06, 2020 (GLOBE NEWSWIRE) — A novel strategy has been developed by Novateur Ventures, which provides new hope in battle against COVID-19. The study titled ‘A… Read More
SEATTLE, Aug. 06, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that management will participate in… Read More
August 5, 2020 – Ottawa, Ontario The Government of Canada is aggressively pursuing the purchase and development of COVID-19 vaccines, treatments and related supplies to protect Canadians and is working… Read More
WARMINSTER, Pa., Aug. 05, 2020 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on developing a cure for people with chronic hepatitis B virus… Read More
SEATTLE, Aug. 05, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc. “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced it will report second quarter… Read More
